AGN Stock Price Today $154.98
Year To Date
The Year To Date (YTD) return is -9.01%.
52 Week Low
The 52 Week Low stock price is 142.81 set on Mon, Mar 5, 2018 which is 79 days ago.
The current price per share is 8.52% above the 52 week low.
52 Week High
The 52 Week High stock price is $256.80 set on Tue, Jul 25, 2017 which is 302 days ago.
The current price per share is -39.65% below the 52 week high.
All Time High
The All Time High stock price is $340.34 set on Wed, Jul 29, 2015 which is 1,029 days ago.
The current price per share is -54.46% below the all time high.
Allergan Stock Charts
5 Year Stock Chart
The Allergan 5 year stock chart shows the historical prices over the previous 60 months.
1 Year Stock Chart
The Allergan 1 year stock chart shows the historical prices over the previous 12 months.
50 Day Moving Average
The 50 Day Moving Average is at $159.55 which is 2.86% above the stock price of $154.98.
200 Day Moving Average
The 200 Day Moving Average is at 180.38 which is 14.08% above the stock price of $154.98.
Because both the 50 DMA and 200 DMA are above the current stock price, this can be considered a bearish technical indicator.
AGN Company Profile
Allergan PLC is a Health Care stock that trades on the NYSE and has a market capitalization of $52.68 Billion.
Allergan plc is a specialty pharmaceutical company. The Company is engaged in the development, manufacturing, marketing and distribution of brand name pharmaceutical products, medical aesthetics, biosimilar and over-the-counter pharmaceutical products. The Company operates through three segments: US Specialized Therapeutics, US General Medicine and International. The US Specialized Therapeutics segment includes sales relating to branded products within the United States, including Medical Aesthetics, Medical Dermatology, Eye Care, Neurosciences and Urology therapeutic products. The US General Medicine segment includes sales relating to branded products within the United States that do not fall into the US Specialized Therapeutics business units, including Central Nervous System, Gastrointestinal, Women's Health, Anti-Infectives and Diversified Brands. The International segment includes sales relating to products sold outside the United States.
Below are several other Biotech & Pharma stocks include AbbVie Inc (ABBV), Allergan PLC (AGN), Alexion Pharmaceuticals Inc (ALXN), Amgen Inc (AMGN), Biogen Inc (BIIB), BioMarin Pharmaceutical Inc (BMRN), Bristol-Myers Squibb Co (BMY), Celgene Corp (CELG), Endo International PLC (ENDP), Gilead Sciences Inc (GILD), .
Earnings Per Share
The EPS is -$13.2 and the P/E Ratio is 0.
A negative Earnings Per Share (EPS) means that this company is losing money and not profitable at this time.
Stocks can make big percentage moves on the earnings announcement.
Companies announce earnings either before the market open or after the close.
The Earnings Release Date for Allergan PLC was Tue, Feb 6, 2018.
Since this earnings release 106 days ago, the stock price is down by -6.07%.
Many investors know the importance of a companies earnings report. Also, the market reaction to the earnings release can be even more important and can help in making a prediction of a future price forecast of the shares.
A significant post earnings announcement percentage move can continue or reverse an existing trend for several days or weeks after the earnings date.
The most recent Earnings Release Date was on Mon, Apr 30, 2018, which was 23 days ago.
Since this earnings date, the stock price is down by -4.36%.